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Abstract: The field of bioinformatics and computational
biology has gone through a number of transformations
during the past 15 years, establishing itself as a key
component of new biology. This spectacular growth has
been challenged by a number of disruptive changes in
science and technology. Despite the apparent fatigue of
the linguistic use of the term itself, bioinformatics has
grown perhaps to a point beyond recognition. We explore
both historical aspects and future trends and argue that
as the field expands, key questions remain unanswered
and acquire new meaning while at the same time the
range of applications is widening to cover an ever
increasing number of biological disciplines. These trends
appear to be pointing to a redefinition of certain
objectives, milestones, and possibly the field itself.
This is an ‘‘Editors’ Outlook’’ article for PLoS Computational
Biology.
In Lieu of an Introduction
After considerable deliberation and multiple discussions with
colleagues over the last couple of years, and having written several
retrospective assessments, I would like to touch upon yet another
historical aspect of the field of computational biology [1]. The
intention here is to explore the rise and demise of the term
‘‘bioinformatics’’ and how its linguistic use might reflect trends in
the field per se. I will be citing a rather unconventional corpus of
editorials, vision statements, government strategy reports, quasi-
commercial think tank documents, and the media. This statement
is necessary to qualify the approach without alienating readers
accustomed to a more academic style. I will examine two key
aspects of computational biology, namely, its heavily technological
nature and its support role for other biological disciplines [2].
These trends may be useful to anticipate future avenues of
research and applications, and explore the fundamental impor-
tance of this scientific endeavor for the life sciences [3].
Declining Trends?
One might well wonder whether the term ‘‘bioinformatics’’ is no
longer in vogue, compared to those years a decade ago when its
use seemed to be associated with great excitement and the
anticipation of a new era. A casual look into Google Trends
suggests a remarkable pattern of decline in appearances in Google
News. To wit, the use of the term ‘‘bioinformatics’’, largely
reflecting news feeds for the discipline, has diminished by almost 6-
fold over the past 7 years (Figure 1). The trend equation is an
exponential of this form: y=2.1395e
20.0047x and a R
2 factor=
0.9636, signifying that the trend may reach y=0.1, i.e., virtually
irrelevance, in x=651 weeks, or just over a dozen years from now.
Such a trend cries out for an explanation. Why is it that a field that
appeared unstoppable in all its glory just a few years ago might
already be exhibiting signs of (media) fatigue? And does this trend
indicatelack ofprogress, lack ofinterest, both,or none of the above?
We take this graph as a stepping stone, an opportunity to discuss the
above questions, bearing in mind that this is a trends analysis and
not a strictly scientific discourse on the subject.
One Explanation: Too Much Promise?
One way to assess the development of bioinformatics and its
promised progress is by examining predictions made when the
field first entered the limelight. While one might think the field was
overly hyped, in fact most past statements have been reasonably
balanced, measured, and only subtly evangelical for the establish-
ment of computational research within the life sciences, a
monumental task probably accomplished successfully. The
selected corpus here covers 15 years or so, split artificially into
three periods, which I will define as the ‘‘infancy’’ (1996–2001),
‘‘adolescence’’ (2002–2006), and ‘‘adulthood’’ (2007–2011) peri-
ods. This selection was based solely on relevance regarding
challenges and opportunities for the field, and does not depend on
impact, e.g., status of journal or number of received citations. In
this manner, my hope is that this eclectic mix of references is as
inclusive as possible, thus better representing a range of opinions
voiced during these periods and not too biased by particular
specialties, institutions, or journals.
The ‘‘Infancy’’ Period: 1996–2001
During the ‘‘infancy’’ period, the perception for the wider
public, including biologists, was that this was a new field. Yet,
much had already happened: the basic ideas were in place, some
key algorithms were fully developed, and database resources were
being built up [4]. Already, there were debates about the
interoperability of database systems with the newly arrived HTTP
protocols and other mechanisms, as well as social elements,
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requirements [5]. The job market was virtually exploding and
demand was exceeding supply: there was a sense that Europe was
lagging behind the United States and efforts were put in place to
secure funding [6]. This is the time when most graduate programs
in bioinformatics were being established, under the guidance of
the recently founded International Society for Computational
Biology [7]. In a period that feels so long ago, there was a
realization that bioinformatics, properly coupled with high-
throughput biology, had the potential to transform biomedical
research [7,8]. The terms ‘‘flood’’ and ‘‘explosion’’ as applied to
ever-increasing data volumes were in wide use [9] (much more
than terms such as ‘‘tsunami’’ or ‘‘avalanche’’, for some reason);
this explosion of sorts was expected to challenge ‘‘data organiza-
tion, accessibility and, most importantly, interpretation’’ [9]. Many
of these challenges remain with us today, in the same order
(interpretation being the hardest part). Predictions of ‘‘laboratory
miniaturization and non-destructive technologies’’ were heralding
the dawn of ‘‘systems biology’’ [10]. On the systems side, it was
envisioned that humans would flock to computer systems (not the
other way around, as we are experiencing today, in the era of
ubiquitous computing) [10]. On the data side, it was noted that the
inevitable use of automated approaches had ‘‘led to much
database misinformation’’ [11]. This was the era of ontology
and vocabulary designs and more extensive database cross-
referencing. The nature of the data was ‘‘global’’: it was genes,
sequences, structures, expression profiles, and genomes, reflected
in the content of the most well-known molecular biology
databases, providing opportunities for the coupling of high-
throughput experimentation to computational research [12,13].
Slowly, the medical fields were embracing high-throughput
methodologies and the genomics revolution [14]. In industry,
numerous business opportunities existed and the growth outlook
was very positive [15]. Away from applications, there was also a
conceptual shift in biology, and the opinion that we were moving
into a new science, where we would be striving ‘‘to develop higher-
order algorithms for linking data, structures, and functions in
networks’’ [16]. As a result, funding was increasing: for example,
the European Bioinformatics Institute’s budget doubled during
this period [17]. Infrastructures were already deemed essential for
the field to move forward [18]. Issues of data release and
accessibility policies [19] as well as intellectual property protected
by patents were also emerging during this early period: ‘‘the legal
treatment of inventions in bioinformatics is in its infancy’’ [20].
This short journey into the not-so-distant past hopefully provides a
flavor of the fluidity of the field during its early period [21]. On the
whole, I would suggest that most public statements during this
early phase were reasonably measured and did not oversimplify
the challenges and anticipated directions of computational biology
into the 21st century.
The ‘‘Adolescence’’ Period: 2002–2006
By now, the field was already in the limelight, after the famous
Clinton-Blair handshake for the completion of the human genome
in 2000. It made sensational headlines such as ‘‘the laboratory rat
is giving way to the computer mouse’’, partly to explain the
multibillion dollar markets [22]. Various agencies were now
scrutinizing strategies for the support of the field and playing out
different scenarios, for example whether there would be a
‘‘Europe-wide integration or coherent strategy’’ by 2006 [23].
One crucial observation was that bioinformatics was moving
outside its comfort zone into new territories with new data types,
‘‘toward ‘real’ biology’’ [24]—this point will be discussed below.
Clearly, the impact of expression profiling was being felt in the
community [25]. From its humble roots in molecular biology,
computational biology was coming up in the world, reaching the
realms of computational cell biology [26]. Computation was not
only going deeper into the cell, it was becoming broader, too:
already, dozens of genomes increasing to 100 or more were being
sequenced and, among other issues, multiple genome comparison
was now emerging as a topic of research [27]. Structural genomics
was being established and faced new challenges, e.g., metadata
tracking [28]. Vision statements about the future of biological
research were now taking into account the multidisciplinary nature
of the field, broadening its horizons [29]. There was now a solid
acknowledgment of the human element in the automation utopia
previously offered by bioinformatics [30], called the ‘‘people
paradox’’: the realization that ‘‘the application of computer
science to biology results in an increase in the demand for people’’
[31]. At the same time, the notion of ‘‘personalized medicine’’ and
data sharing in pharmacogenomics [32] increased the stakes and
established the flagship role of bioinformatics in this new era [33].
This impact was felt in emerging fields as well, synthetic biology
being the latest arrival [34]. Yet, in virtually all expositions, the
issue of data integration was repeatedly appearing [35] and was
being addressed by the rapid development of bio-ontologies and
controlled vocabularies [36]. It seemed that no matter how much
effort was in place, the ‘‘people paradox’’ was reemerging to haunt
us [37]. This was the time of the appearance of specialized
disciplines within the field, e.g., for agriculture [38], generating
even more complex and domain-specific data types [39,40].
Robotics and automation platforms were propagating into
medicine rapidly [41,42]. It was becoming clearer that the fusion
of disciplines was far deeper than simply computing and biology
[43]: moving into public health, ethical, legal, and social issues
needed to be taken into account [44], along with educational or
epistemological elements [45]. There were concerns, however,
that the pace of discovery and wider applications in medical
biotechnology were not delivering against high expectations, with
the realization that the otherwise productive ‘‘shift from craft-
Figure 1. Use of the term ‘‘bioinformatics’’ in Google Trends.
The use of the term ‘‘bioinformatics’’ in Google Trends (http://www.
google.com/trends?q=bioinformatics&ctab=0&geo=all&date=all&sort=0)
plotted with relative scaling, i.e., scaled to the average search traffic for the
term (y-axis) during the time period (x-axis) (for additional explanations,
check the About document http://www.google.com/intl/en/trends/about.
html). The trend equation and the R
2 factor are also shown.
doi:10.1371/journal.pcbi.1002487.g001
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bottlenecks downstream in the discovery process [46]. One factor
in policymakers’ high expectations might have been a certain lack
of milestones: due to the field’s dual nature, that of science and
engineering, computational biology rarely has the ‘‘eureka’’
moment of a scientist’s discovery and is grounded in the laborious
yet inspired process of an engineer’s invention. At the same time,
much effort was being invested in formulating training and
curriculum development [47,48]. We thus reached a turning
point, with bioinformatics and computational biology finding its
place as a key discipline both within life science and biological
technology [49].
The ‘‘Adulthood’’ Period: 2007–2011
Admittedly, there is no clear dividing line for the next transition.
Placing it between years 2006 and 2007 might reflect a certain
symmetry—or, on a more personal note, the beginning of a new
journey after a long appointment. Nevertheless, it is evident that
during the past 5 years, we have moved into a new phase, that—if
understood properly—can help us define our future strategy. By
2007, things had become more sophisticated: text mining could
now be used in trends analysis of the field for decision making
[50], ontology development was proliferating into every aspect of
computing [51], and bioinformatics was pervasive in the life
sciences, for example, extending to biodiversity conservation
planning [52] or synthetic biology [53]. Besides the more
theoretical aspects of network biology [54], exemplified by gene
and protein interaction networks, pressure mounted for support of
translational medicine, ranging from structural variation [55] to
cancer bioinformatics [56]. Due to the initial excitement, some
mistakes of the past were reappearing, for instance in the reporting
of structural variants, for which ‘‘there has been no standard
approach to collecting the data, assessing its quality or describing
identified features’’ [55]—reminiscent of function annotation a
decade earlier. On another level, the challenges were not
dissimilar from the ones that the field had been experiencing all
along: ‘‘managing a huge data volume, integrating information
from various discovery platforms and discerning phenotypic
implications’’ [55]. In the midst of this next wave, biologists had
to adapt yet again to a bewildering new array of software suites
with more emphasis on ‘‘user-friendly’’ software: ‘‘biological
intuitiveness and investigator empowerment need to take prece-
dence over the current supposition that biologists should re-tool
and become programmers when analyzing genome scale datasets’’
[57]. A ‘‘deja-vu’’ feeling around education and training appeared,
for instance with regard to training clinicians in the translational
realm of genomic medicine, evidently including bioinformatics
[58]. At the same time, new problems were emerging, related to
next-generation sequencing efforts, ranging from resequencing to
metagenomics [59]. This new data stream was necessarily closer to
the platforms generating it, rather than the more detached,
‘‘classical’’ bioinformatics data types (genes, proteins, networks,
genomes); it has now become ‘‘real’’ indeed [24]! More traditional
problems are still with us today, such as drug [60] and biomarker
[61] discovery, data curation [62], literature mining [63], and
workflow development [64]. The prediction in 2008 was that in 10
years, we will possess an adequate infrastructure for biological
research [65], in a fusion of disciplines [66]. Switching to the
present, we are now faced with an expansion of problems, ranging
from genome assembly [67], protein design [68], or metagenomics
[69] to genomic medicine [70], infectious disease [71], and
phenotyping [72]. The latter few deserve verbatim citations, since
these activities are also now becoming ‘‘real’’, very real. On the
metagenomics front, it has been noted that ‘‘to understand how
the Earth breathes, grows, evolves, renews and sustains life is the
great adventure now beckoning to us’’ [69]. For genomic
medicine, we hear that ‘‘systems medicine should be developed
through an international network […] dedicated to inter-
disciplinary training and education, to help reduce the gap in
healthcare between developed and developing countries’’ [70] and
that as ‘‘microorganisms do not follow national borders, such
initiatives are probably best started from intergovernmental
organizations […], to facilitate the spread of new concepts and
software […]’’ [71]. In a sense, the genomics-bioinformatics nexus
has now spilled into the real world [73]. Challenges for health,
food and feed, materials, fuels, energy sources. and the
environment are all on the agenda [74]. The expectations are
high and the stakes have never been greater.
Another Explanation: Too Much Progress
It might be readily obvious by now in this essay that the
‘‘decline’’ of media interest and the potential diminution of the
linguistic use of ‘‘bioinformatics’’ might not reflect the knee-jerk
explanation of ‘‘too much promise’’. As we have suggested above,
expectations in the past 15 years have generally been modest and
realistic within the community of computational biology. Despite
the great challenges of managing outside expectations, commercial
opportunity, legal and ethical issues, educational and training
needs, as well as multiple disruptive technologies, from the Web to
mobile devices, the field has not only contributed to the omics
revolution, but also has established a basis for a transformation of
biology into a quantitative science. In that sense, an alternative,
perhaps fairer, explanation for this apparent decline might be that,
indeed, there has been too much progress, if anything. To catalog
some of the recent efforts, in an ad hoc manner, one can mention
links to synthetic biology [75,76], protein docking [77], systems
medicine or physiology [78,79], translational [80] and personal-
ized medicine [81], or genome-wide association studies [82].
Despite some negative press coverage at times [83], there has been
tremendous progress towards the establishment of computing in
virtually every realm of life sciences. Yet, old problems remain
with us and should not be neglected, for instance database
searches, multiple alignment, orthology detection, structure-
function or species relationships, and protein annotation [84].
With a whole new level in data volumes, all these problems come
back with a vengeance—including training, once again [85].
From Global to Local—And Back
The above exposition is an attempt to provide a quick tour of
what has happened in the past 15 years in the field. The focus has
been the perception of the field and not just the substance: when
this investigation began, I was searching for blatant over-
statements in the literature, yet I found few. Thus, it can be
argued that the declining trend might be attributed mostly to the
nature of the field, which found itself in the midst of the turmoil of
a wider transformation, driven by industrial and social needs. In
other words, it is not lack of interest and definitely not lack of
progress: instead, it might be exactly the opposite. The vast
progress and the dislocation of traditional biological research into
a more precise and quantitative science has moved computational
biology from the fringes to the eye of the storm.
Two remarks that address some of the other questions raised
above follow. First, the shift from academic exploration to real-
world applications and the extension of range both deeply into the
cell and widely across all levels of biological organization drives
computation to become increasingly local. A few years back, it
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‘‘chunks’’ of data and a workstation. It seemed as if we would be
needing more and more storage and compute capacity to execute
any significant research and that scaling up was the only way
forward. Yet, and thanks to the infrastructures now in place as well
as the idiosyncrasies of the new breed of data generation platforms,
it is becoming possible to scale down and still explore certain
problems effectively. In a subtle yet significant manner, both
biological data and computer power seem to be appearing out of
the mists of the Internet cloud. Data might be richer, and in small,
potent doses and high concentrations can generate fascinating
results. Similarly, compute power is becoming available in various
ways and unexpected locations. The nature of the game is
changing: from an effort to concentrate as much data as possible
and throw them to large computers, we might be experiencing
something much more effervescent instead. It will be the right mix
of data and machines that will derive small packages of high-value
products, exciting new science. Biological computation might start
producing the equivalent of perfume or spice for scientific and
medical research, without excluding of course the bulk, staple food
equivalent, which we were accustomed to, until the recent past.
Second, it is interesting that many key questions that have been
considered solved are coming back to us on a whole new and
different level. We listed some of scientific questions above; these
can be coupled to ever present social themes such as the blissful
anarchy and subsequent management of novel exciting data types,
the cybertopia of automatic data interpretation, the apparently
endless need for education and training, the chimera of data
integration, and most importantly, the dual nature of the field. An
honest self-assessment and the definition of relevant milestones
have the potential for supporting the proper public understanding
of bioinformatics and better, wiser expectations management.
Epilogue
The notion of computing in biology, virtually a religious
argument just 10 years ago [2], is now enthroned as the pillar of
new biology. This is the reason that despite the apparent fatigue,
infrastructures for the computational analysis of biological systems
are expanding, and moving from research labs into the main-
stream. At the same time, this fusion of computational biology with
most biology makes it harder for the field to stand out and clearly
remain isolated: as predicted years ago, ‘‘this discipline will
continue to evolve rapidly into the 21st century, perhaps to a point
beyond recognition’’ [4]. It might be that a new, ‘‘theoretical
biology’’ is emerging, where models and their predictions can now
be assessed by experimental biology, in analogy to the interplay
between theoretical and experimental physics. This moment might
have come faster than expected. The merging of computation into
the fabric of biosciences and biomedicine by 2020, while acquiring
a key, critical position amongst other technologies in the toolkit,
will possibly necessitate a redefinition of computational biology as
a distinct discipline in the not-so-distant future.
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